EyeArt is an FDA-cleared, autonomous AI system developed by Eyenuk that analyzes retinal images to detect diabetic retinopathy, enabling healthcare providers in primary care, diabetes centers, and optometric offices to quickly and accurately identify patients with referable diabetic retinopathy during a regular exam. Its key features include autonomous analysis of retinal images with an easy-to-read report produced in under sixty seconds, without requiring expert human grading or pupil dilation in most cases, compatibility with Canon and Topcon fundus cameras, and (in the EU) CE marking for detecting age-related macular degeneration and glaucomatous optic nerve damage. It’s designed for primary care physicians, diabetes clinics, and eye-care practices rather than individual consumers, and has been tested in the real world on more than half a million patients and nearly two million retinal images globally.
Leave a Reply